Repare Therapeutics (RPTX) Stock Highlights

1.32 | +0%

2024-12-21 06:34:25

Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Using its SNIPRx platform, it is developing pipeline of SL product candidates, including its product candidate, RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations.

Statistics

Range Today

1.3 1.45

Volume Today 1.09M

Range 1 Year

1.23 8.49

Volume 1 Year 51.1M

Range 3 Year

1.23 23.7

Volume 3 Year 181.62M

Range 10 Year

1.23 46.44

Volume 10 Year 243.01M

Highlights

Market Capitalization 152.38M (small)

Floating Shares 20.11M

Current Price 1.32

Price To Earnings -2.06

Price To Revenue -0.78

Price To Book 0.75

Earnings Per Share -1.68

Payout Ratio 0%

Performance

Latest 0%

1 Month -54.33%

3 Months -62.18%

6 Months -63.33%

1 Year -80.36%

3 Years -93.58%

5 Years -95.94%

10 Years -95.94%

Benchmarks

Market Capitalization

207 / 368

Gross Profits

92 / 278

Total Revenue

115 / 300

Total Rank

31 / 368

Free Cashflow

233 / 352

Performance 5 years

329 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.